2.11% -0.045

Cellectar Biosciences Inc (CLRB)

Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie

Cellectar Biosciences Inc (CLRB)

Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie

Cellectar Biosciences (NASDAQ:CLRB) Stock Quotes, Forecast and News Summary - Benzinga

Cellectar Biosciences (NASDAQ:CLRB) Stock Passes Below 200 Day Moving Average of $2.99 - Defense World

Cellectar Biosciences (NASDAQ:CLRB) Stock Price Passes Below 200 Day Moving Average of $2.99 - MarketBeat

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Short Interest Update - MarketBeat

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131 - MSN

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131 - Zacks Investment Research

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131 - Yahoo Finance

Iopofosine I 131 Featured in Two Separate Presentations at - GlobeNewswire

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia - StockTitan

Cellectar receives delinquency notification letter from Nasdaq, co to restate financial statements - MSN

Cellectar to Restate Previously Issued Financial Statements - GlobeNewswire

Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq - StockTitan

Neuroblastoma Drugs Market to Witness Huge Growth by 2031 - openPR

Vanguard Group Inc. Buys 708,191 Shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB) - MarketBeat

Vanguard Group Inc. Has $4.74 Million Holdings in Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Defense World

Equities Analysts Set Expectations for Cellectar Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:CLRB) - Defense World

Equities Analysts Set Expectations for Cellectar Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:CLRB) - MarketBeat

FY2027 Earnings Forecast for Cellectar Biosciences, Inc. Issued By Roth Capital (NASDAQ:CLRB) - Defense World

FY2027 Earnings Estimate for Cellectar Biosciences, Inc. Issued By Roth Capital (NASDAQ:CLRB) - MarketBeat

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Cellectar Biosciences reports strong trial results for iopofosine By Investing.com - Investing.com Canada

Earnings call: Cellectar Biosciences reports strong trial results for iopofosine - Investing.com

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update - GlobeNewswire

CLRBCellectar Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Cellectar Biosciences sees cash balance sufficient into 2Q25 - TipRanks

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update - StockTitan

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update - Yahoo Finance

Here's Why You Should Retain Accuray (ARAY) Stock for Now - Zacks Investment Research

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday - Defense World

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday - MarketBeat

UPDATE -- Cellectar Biosciences to Announce Second Quarter - GlobeNewswire

UPDATE — Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 - ForexTV.com

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 - StockTitan

Cellectar Biosciences to Announce First Quarter Financial - GlobeNewswire

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 - StockTitan

We Think Cellectar Biosciences (NASDAQ:CLRB) Needs To Drive Business Growth Carefully - Simply Wall St

Cellectar Biosciences (NASDAQ:CLRB) Stock Passes Below Two Hundred Day Moving Average of $3.23 - Defense World

Cellectar Biosciences (NASDAQ:CLRB) Stock Passes Below Two Hundred Day Moving Average of $3.23 - MarketBeat

CLRB (Cellectar Biosciences) GF Value : $0.00 (As of Aug. 07, 2024) - GuruFocus.com

It is Poised to be a Bull Market for Cellectar Biosciences Inc (CLRB) - SETE News

Insider’s View: Deciphering Cellectar Biosciences Inc (CLRB)’s Financial Health Through Ratios - The Dwinnex

Top investors say Cellectar Biosciences Inc (CLRB) ticks everything they need - SETE News

The Psychology of Cellectar Biosciences Inc Inc. (CLRB) Price Performance: Understanding Market Sentiment - The InvestChronicle

Was Cellectar Biosciences Inc (CLRB)’s session last reading good? - US Post News

Balance Sheet Breakdown: Cellectar Biosciences Inc (CLRB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Bone Cancer Drugs Market is expected to reach US$ 1,830.6 Mn with - openPR

Roth Capital Comments on Cellectar Biosciences, Inc.'s FY2026 Earnings (NASDAQ:CLRB) - MarketBeat

Research Analysts Offer Predictions for Cellectar Biosciences, Inc.’s FY2026 Earnings (NASDAQ:CLRB) - Defense World

FY2028 EPS Estimates for Cellectar Biosciences, Inc. Cut by Analyst (NASDAQ:CLRB) - American Banking and Market News

FY2028 EPS Estimates for Cellectar Biosciences, Inc. Cut by Analyst (NASDAQ:CLRB) - Defense World

Analysts Set Expectations for TransAlta Co.’s Q2 2024 Earnings (TSE:TA) - Defense World

National Bank Financial Comments on Atco Ltd.’s Q2 2024 Earnings (TSE:ACO) - Defense World

Raymond James Research Analysts Boost Earnings Estimates for MAG Silver Corp. (TSE:MAG) - Defense World

Cormark Weighs in on Fairfax Financial Holdings Limited’s Q2 2024 Earnings (TSE:FFH) - Defense World

Centaur Media Plc (LON:CAU) Insider Swagatam Mukerji Sells 390,329 Shares of Stock - Defense World

Analysts Issue Forecasts for Doman Building Materials Group Ltd.’s Q2 2024 Earnings (TSE:DBM) - Defense World

Calibre Mining Corp. Expected to Earn Q2 2024 Earnings of $0.04 Per Share (TSE:CXB) - Defense World

Steel Partners (NYSE:SPLP) Receives New Coverage from Analysts at StockNews.com - Defense World

Roth Capital Equities Analysts Decrease Earnings Estimates for W&T Offshore, Inc. (NYSE:WTI) - Defense World

ECN Capital Corp. (TSE:ECN) Expected to Post Q2 2024 Earnings of $0.04 Per Share - Defense World

Summit Materials, Inc. (NYSE:SUM) Shares Sold by Russell Investments Group Ltd. - Defense World

SilverCrest Metals Inc. to Post Q2 2024 Earnings of $0.23 Per Share, Cormark Forecasts (TSE:SIL) - Defense World

Simile a CLRB